Cerebral Microembolism in the Critically Ill With Acute Kidney Injury
NCT ID: NCT02621749
Last Updated: 2022-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
66 participants
INTERVENTIONAL
2017-01-31
2022-11-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebral Microemboli in Venoarterial ECMO Patients
NCT02020759
Endovascular Therapy for Large Core Patients With Uncertain Response to Thrombectomy
NCT06961487
Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms
NCT02862756
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
NCT04178746
PeRforation EVents During ENdovascular Therapy for Acute Ischemic Stroke
NCT06394180
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRRT group
the CRRT group receives continuous renal replacement therapy for acute kidney injury
Renal replacement therapy
Patients receive renal replacement therapy according to institutional standards
IRRT group
the IRRT group receives intermittent renal replacement therapy after termination of CRRT.
Renal replacement therapy
Patients receive renal replacement therapy according to institutional standards
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Renal replacement therapy
Patients receive renal replacement therapy according to institutional standards
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed IC
Exclusion Criteria
* Atrial fibrillation
* Cerebrovascular pathology
* Missing temporal bone window
* Allergy to plastic contained in the investigative device (transcranial Doppler)
* Chronic kidney disease
* Pregnancy
* Participation in another study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabor Erdoes, MD
Role: PRINCIPAL_INVESTIGATOR
University of Berne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Erdoes G, Uehlinger DE, Kobel B, Stucki MP, Wiest R, Stueber F, Fankhauser N, Jakob SM, Schefold JC. Cerebral microembolism in the critically ill with acute kidney injury (COMET-AKI trial): study protocol for a randomized controlled clinical trial. Trials. 2018 Mar 21;19(1):189. doi: 10.1186/s13063-018-2561-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
199/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.